2018
DOI: 10.1038/s10038-018-0492-1
|View full text |Cite
|
Sign up to set email alerts
|

Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features

Abstract: Pediatric cardiomyopathy is a complex disease with clinical and genetic heterogeneity. Recently, the ALPK3 gene was described as a new hereditary cardiomyopathy gene underlying pediatric cardiomyopathies. Only eight patients carrying mutations in ALPK3 have been reported to date. Here, we report a 3-year-old male patient with both hypertrophic and dilated cardiomyopathy. The patient presented dysmorphic features and skeletal deformities of hands and feet, pectus excavatum, and cleft palate. The genetic investi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 16 publications
1
10
0
Order By: Relevance
“…This further includes the variability of the skeletal and muscle system involvement in ALPK3 -associated cardiomyopathy. Musculoskeletal abnormalities were not reported in all patients with pathogenic ALPK3 variants, and examples of reported abnormalities included subtle signs of muscle weakness, dysmorphic features and skeletal abnormalities [ 8 , 9 ]. In the presented cases, both patients revealed decreased muscle tone, axial weakness and clinical signs of polyneuropathy, but no defined changes were detected in Patient 2 using neurography and electromyography.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This further includes the variability of the skeletal and muscle system involvement in ALPK3 -associated cardiomyopathy. Musculoskeletal abnormalities were not reported in all patients with pathogenic ALPK3 variants, and examples of reported abnormalities included subtle signs of muscle weakness, dysmorphic features and skeletal abnormalities [ 8 , 9 ]. In the presented cases, both patients revealed decreased muscle tone, axial weakness and clinical signs of polyneuropathy, but no defined changes were detected in Patient 2 using neurography and electromyography.…”
Section: Discussionmentioning
confidence: 99%
“…Hitherto, 27 patients with hypertrophic cardiomyopathy, caused by 19 different mutations in ALPK3 , have been described [ 4 , 7 , 8 , 9 , 10 , 11 ] ( Table 1 ). All but two of the described patients presented before the age of 18 and, apart from HCM, often revealed musculoskeletal abnormalities.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…ALPK3 (alpha kinase 3) is implicated in a large variety of cellular processes such as protein translation, Mg 2+ homeostasis, intracellular transport, cell migration, adhesion, and proliferation [95]. A mutation in the ALPK3 gene in human is associated with cardiomyopathy [96]. The overexpression of ALPK3 enhances differentiation of murine embryonic carcinoma cells into cardiomyocytes [95].…”
Section: Candidate Gene Identificationmentioning
confidence: 99%
“…The highest ALPK3 transcript expression profile in humans is observed in cardiac and skeletal muscle, and the GeneNetwork Assisted Diagnostic Optimization (GADO) method predicts "muscle contraction" and "myogenesis" as probable gene functions . [4][5][6][7][8][9][10][11] Nevertheless, clinically evident skeletal myopathy is not known to be associated with ALPK3 genetic variants. We present a patient showing both cardiac and skeletal muscle involvement linked to a novel homozygous ALPK3 variant.…”
Section: Introductionmentioning
confidence: 99%